NewGenIvf Group Total Liabilities 1970-1969 | NIVF

NewGenIvf Group total liabilities from 1970 to 1969. Total liabilities can be defined as the total value of all possible claims against the corporation.
NewGenIvf Group Annual Total Liabilities
(Millions of US $)
2021 $
NewGenIvf Group Quarterly Total Liabilities
(Millions of US $)
Sector Industry Market Cap Revenue
Medical Medical Services $0.005B $0.000B
NewGenIvf Limited is a comprehensive fertility services provider principally in Asia helping couples and individuals obtain access to fertility treatments. NewGenIvf, formerly known as A SPAC I Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $122.475B 15.37
Cencora (COR) United States $44.674B 17.41
ICON (ICLR) Ireland $25.493B 24.07
DiDi Global (DIDIY) China $24.448B 0.00
Avantor (AVTR) United States $16.791B 24.72
Viatris (VTRS) United States $14.026B 4.03
CochLear (CHEOY) Australia $13.917B 0.00
Revvity (RVTY) United States $12.428B 21.78
Medpace Holdings (MEDP) United States $12.163B 40.02
Charles River Laboratories (CRL) United States $12.026B 21.92
Natera (NTRA) United States $11.711B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $11.540B 0.00
Solventum (SOLV) United States $11.153B 0.00
Sonic Healthcare (SKHHY) Australia $8.297B 0.00
HealthEquity (HQY) United States $6.740B 50.35
Organon (OGN) United States $5.043B 4.78
Bausch + Lomb (BLCO) Canada $4.779B 19.15
Doximity (DOCS) United States $4.494B 33.46
PACS (PACS) United States $3.725B 0.00
Sotera Health (SHC) United States $3.119B 15.31
Surgery Partners (SGRY) United States $3.118B 28.86
Progyny (PGNY) United States $3.049B 51.16
GoodRx Holdings (GDRX) United States $2.804B 142.00
Life Times (LTH) United States $2.783B 29.48
Premier (PINC) United States $2.460B 9.00
AMN Healthcare Services Inc (AMN) United States $2.256B 7.30
Teladoc Health (TDOC) United States $2.167B 0.00
Agilon Health (AGL) United States $1.985B 0.00
BrightSpring Health Services (BTSG) United States $1.969B 0.00
NovoCure (NVCR) Jersey $1.590B 0.00
Establishment Labs Holdings (ESTA) $1.451B 0.00
Agiliti (AGTI) United States $1.374B 22.44
Alignment Healthcare (ALHC) United States $1.264B 0.00
Pediatrix Medical (MD) United States $0.784B 8.11
Embecta (EMBC) United States $0.584B 3.86
InnovAge Holding (INNV) United States $0.549B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.528B 0.00
GeneDx Holdings (WGS) United States $0.512B 0.00
LifeMD (LFMD) United States $0.512B 0.00
Enhabit (EHAB) United States $0.511B 46.27
CareDx (CDNA) United States $0.503B 0.00
Auna S.A (AUNA) Luxembourg $0.480B 0.00
Sonida Senior Living (SNDA) United States $0.463B 0.00
MultiPlan (MPLN) United States $0.422B 0.00
Beauty Health (SKIN) United States $0.415B 0.00
ModivCare (MODV) United States $0.383B 7.18
DocGo (DCGO) United States $0.376B 60.17
Sera Prognostics (SERA) United States $0.352B 0.00
Sharecare (SHCR) United States $0.270B 0.00
Ascend Wellness Holdings (AAWH) United States $0.265B 0.00
Biodesix (BDSX) United States $0.161B 0.00
So-Young (SY) China $0.128B 43.00
Oncology Institute (TOI) United States $0.080B 0.00
Pono Capital Two (PTWO) United States $0.075B 0.00
IceCure Medical (ICCM) Israel $0.054B 0.00
NeueHealth (NEUE) United States $0.051B 0.00
Co-Diagnostics (CODX) United States $0.038B 0.00
Nutex Health (NUTX) United States $0.034B 0.00
SeaStar Medical Holding (ICU) United States $0.033B 0.00
Singular Genomics Systems (OMIC) United States $0.031B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.030B 0.00
OncoCyte (OCX) United States $0.022B 0.00
DermTech (DMTK) United States $0.022B 0.00
Aesthetic Medical Hldngs Group (AIH) China $0.013B 0.00
BIMI Holdings (BIMI) United States $0.013B 0.00
BioNexus Gene Lab (BGLC) $0.011B 0.00
TRxADE HEALTH (MEDS) United States $0.009B 0.00
XWELL (XWEL) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
OpGen (OPGN) United States $0.006B 0.00
Assure Holdings (IONM) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00